CME Certification

The MCGI GTB sessions feature the presentation of one or more case vignettes, drawn from actual, in-treatment patients who have consented to participate in the MCGI study. Review of all clinical information is done in a coded-manner. Protected health information (PHI) is not disclosed in the GTB meetings.  

Information reviewed includes the patient’s diagnosis, pertinent history of illness, previous treatment approaches, and results from MCGI study-related genomic cancer testing. At the discretion of the presenter, pathology findings and other information about the case pertinent to clinical decision making may also be discussed.  

Commentary and discussion centers on genomic variant interpretation, pathology, oncology, and community knowledge of similar cases. A summary of the discussion of each case is recorded as part of the session's official minutes.

After attendance, participants should be able to:

  • Recognize how gene variants are determined, catalogued, curated, and made meaningful to clinicians;
  • Recognize the application of precision medicine in clinical care;
  • Assess the use of precision medicine in practice by appraising the benefits and limitations of precision medicine for an individual patient case; and
  • Formulate potential treatment approaches based on interpretation of information presented about the case in the genomic tumor board format.


Certified CME Activity 

Target Audience: Maine clinicians practicing oncology, involved in cancer patient care and/or cancer research, who have enrolled in the MCGI study. 

AMA Credit Designation: The Maine Medical Education Trust designates this regularly scheduled series for a maximum of 90.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity. 

Joint Sponsorship: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Maine Medical Education Trust and The Jackson Laboratory. The Maine Medical Education Trust is accredited by the Maine Medical Association Committee on Continuing Medical Education and Accreditation to provide continuing medical education for physicians.

The Maine Medical Education Trust is accredited by the Maine Medical Association to provide CME activities for physicians.


Claiming CME Credit

At the end of the 2023 GTB series, an electronic evaluation will be sent to participants who logged into the VTC, signed an in-person hard copy attendance sheet, and/or made themselves known on the audio teleconference line.

CME credit is AMA PRA Category 1 Credit(s)™ and is intended for physicians; however, the MCGI GTB session series will offer a certificate of participation to attendees who complete the session evaluation at the series' conclusion at the end of the calendar year. For non-clinician participants, it is their responsibility to determine if their respective licensure agency accepts these credits.

Participants may claim credit for each session they attend. A series certificate is provided after the end of the calendar year totaling all credits (or attended hours) for each participant for the 2023 series. 



There is no commercial support for the Maine Cancer Genomics Initiative (MCGI) or its educational activities. MCGI is a program of The Jackson Laboratory funded through a generous grant from the Harold Alfond® Foundation.
The Jackson Laboratory ( is an independent, 501(c)3 nonprofit biomedical research institution with nearly 3,000 employees. Headquartered in Bar Harbor, Maine, it has a National Cancer Institute-designated Cancer Center, a facility in Sacramento, Calif., and a genomic medicine institute in Farmington, Conn. Its mission is to discover precise genomic solutions for disease and empower the global biomedical community in the shared quest to improve human health.
Founded in 1950, Harold Alfond® Foundation furthers the philanthropic legacy of Harold Alfond, the founder of Dexter Shoe Company and a longtime supporter of Maine communities in which he and his family worked and resided. Harold Alfond awarded matching challenge grants to organizations to build community partnerships and to inspire and leverage additional giving by others. He ensured his philanthropy would live on by committing nearly all of his wealth to the Foundation, which continues to support charitable causes in the State of Maine.
Americans with Disabilities Act (ADA):
Services for the Disabled. If special arrangements are required for an individual with a disability to attend this course please contact Jennifer Bourne at The Jackson Laboratory, at 207-288-6113 or